IQVIA Holdings Inc. (IQV)
NYSE
Real-time Data
01:30 PM
Day's Range
252.5652 wk Range
154.50Overview - IQV - IQVIA Holdings Inc.
Key Statistics
Valuation
Enterprise Value
56.80B
P/E (Trailing)
‪32.15‬
P/E (Forward)
‪17.84‬
PEG Ratio
‪-49.84‬
Price / Sales (TTM)
‪2.50‬
Price / Book
‪6.88‬
EV / EBITDA
‪18.63‬
Profitability
Gross Margin
‪32.85%‬
Profit Margin
‪8.09%‬
Operating Margin
‪13.02%‬
Return on Assets
‪5.06%‬
Return on Equity
‪22.81%‬
Ownership
Shares Outstanding
164.60M
Float
156.24M
Short % of Shares Outstanding
‪2.90%‬
Held by Insiders
‪1.08%‬
Held by Institutions
‪103.48%‬
Price stats
Beta
‪1.18‬
50-Day Avg
‪253.80‬
200-Day Avg
‪205.83‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
22 analysts
Average price target
‪$ 275.17‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - IQV - IQVIA Holdings Inc.
Peers - IQV - IQVIA Holdings Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on NYSE.
Profile Summary - IQV - IQVIA Holdings Inc.
About
IQVIA Holdings Inc. is a global healthcare services and analytics company that supports the life sciences industry with clinical research services, commercial insights, and healthcare intelligence. The company combines advanced data, technology solutions, and domain expertise to help pharmaceutical, biotechnology,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
